Maternal structural variations and structural birth defects

Active Grant Awarded

Award ID
R03HD120904
Recipient
Awarding agency
Obligated
$296,320

Award facts

Assistance listing
93.310 Trans-NIH Research Support
Completion date 10% complete
Funding agency
Office of the Director National Institutes of Health, Department of Health and Human Services
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health Office of the Director awarded a grant (R03HD120904) to the University of Texas Health Science Center at Houston on September 9, 2026, with $296,320 obligated under the Trans-NIH Research Support program (CFDA 93.310). The awardee administers the award through its Sponsored Projects Administration Division.

The funded work systematically assesses maternal structural variants (SVs) in relation to offspring outcomes, using population-scale whole-genome sequencing (WGS) data from the KidsFirst program. It addresses the largely unstudied contribution of maternal genetics to structural birth defects. The team's joint-genotyping pipeline has been applied to more than 130,000 WGS samples, enabling association analyses between SVs and cardiovascular and hematologic traits.

The period of performance runs from the September 9, 2026 award date to an ultimate completion date of August 31, 2028. Work is performed in Houston, Texas (ZIP 77030). The instrument is classified as a grant.

Description

Abstract
Birth defects affect over 100,000 infants in the united states each year and are the leading cause of death in the first year of life. Structural malformations constitute a large subset of these conditions. Even after treatments, these disorders can have persistent impacts on quality of life, comprising a significant public health concern. Gaps in knowledge about the underlying causes of these malformations are significantly impeding development of effective primary prevention measures. Although studies of inherited and DE novo genetic variants in the embryo have yielded valuable insights, much less is known about how maternal genetics contributes to fetal structural malformations. Epidemiological findings support a role for maternal genotype in birth defects. For instance, maternal obesity-genetically affected-associates with increased risk of several structural malformations, as well as specific maternal genes involved in folate metabolismand metabolic regulation. Our preliminary data further suggest that maternal single nucleotide polymorphisms (SNPS) contribute to multiple types of structural birth defects. However, the role of maternal structural variants (SVS) has been seriously understudied. SVS are major drivers of genomic diversity and can significantly influence disease risk, yet their contribution to structural birth defects remains largely unknown. Leveraging population-scale whole-genome sequencing (WGS) data from the kidsfirst program provides a unique opportunity to systematically assess maternal SVS in relation to offspring outcomes. Genotyping SVS in large-scale WGS data is a challenging task and our team has developed and successfully applied an efficient pipeline to jointly genotype SVS in >130,000 WGS samples, demonstrating its scalability and sensitivity. This enabled association analyses between SVS and multiple cardiovascular and hematologic traits, successfully revealing several novel genetic associations. We will apply this established pipeline to kidsfirst familial WGS resources to explore novel associations of maternal SVS with structural malformations. The overall objective of this proposal is to determine how maternal structural variants contribute to structural birth defects in offspring. We will approach these goals with these three specific aims: 1) generate a jointly-genotyped SV callset using kidsfirst WGS data from families across multiple structural birth defects; 2) assessing contributions of maternal SVS to structural birth defects and conduct meta-analyses across multiple kidsfirst studies; 3) assessing functional impacts of SVS with short variants to identify causal genetic variations underlying birth defects. By leveraging the rich kidsfirst WGS resource and our robust SV-calling expertise, this project will uncover novel maternal genomic factors influencing the risk of structural malformations.

Quick answers

Who received award R03HD120904?

R03HD120904 was awarded to University Of Texas Health Science Center At Houston by National Institute of Child Health and Human Development (National Institutes of Health) on September 9, 2026.

How much is award R03HD120904 worth?

$296,320 has been obligated on R03HD120904.

Which agency awarded R03HD120904?

National Institute of Child Health and Human Development (National Institutes of Health) awarded R03HD120904, with funding from Office of the Director (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award